RT Journal Article
SR Electronic
T1 Smoking cessation clinic: One year experience
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP P4030
VO 40
IS Suppl 56
A1 Jose Andres García Romero de Tejada
A1 Cristina López Riolobos
A1 Gonzalo Segrelles Calvo
A1 Emma Vazquez Espinosa
A1 Rosa Mar Gómez Punter
A1 Julio Ancochea Bermúdez
A1 Olga Rajas Naranjo
YR 2012
UL http://erj.ersjournals.com/content/40/Suppl_56/P4030.abstract
AB INTRODUCTIONTobacco is the most important preventable cause of premature death worldwide. Only about 4%-7% of people are able to quit smoking on any given attempt without medicines or other help. Smoking cessation clinics and others healthcare providers have been shown to improve smoking cessation rates.AIMTo analyse the characteristics of the smokers in a Smoking Cessation Clinic in Madrid.MATERIAL AND METHODSFrom November 2010 to October 2011, 200 consecutive smokers were included in this study. Demographic data, comorbilities, smoking history, nicotine dependence (Fagerström test scores), motivation to quit (Richmond test scores), treatment and success in quitting smoking were recorded. The statistical software SPSS was used for analysis of the results.RESULTSOur population had a mean age of 51.7 years, with 56% of them being women. Body mass index was 25.35 kg/m2. Mean age at smoking initation was 17.33 years, and men were slightly younger (16.11 vs 17.73, p=0.002). Men also consumed more tobacco (pack-years index was 47.25 in men vs 34.47, p=0.001) and had higher nicotine dependence than women (p 0.019). Six-month continuous abstinence quit rate was 46.43% in women and 30.68% in men (p 0.024). Varenicline was the more effective treatment (success rate 46.91%). 70% of the smokers had tried to quit before, and just 10 patients success at their first attempt (all of them were women). 72 smokers (36%) left the program after the first visit.CONCLUSIONS1. Men significantly started to smoke earlier, consumed more tobacco and had higher nicotine dependence than women.2. Six-month continuous abstinence quit rate was significantly higher in women.3. Varenicline was the more effective treatment for smoking cessation in our experience.